These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7057199)

  • 1. Monoamine oxidase-catalyzed metabolism of 3,4-dihydroxyphenylethylamine in the dopaminergic synaptosomes from rat corpus striatum.
    Katz IR
    J Neurochem; 1982 Mar; 38(3):859-62. PubMed ID: 7057199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guinea pig striatum as a model of human dopamine deamination: the role of monoamine oxidase isozyme ratio, localization, and affinity for substrate in synaptic dopamine metabolism.
    Azzaro AJ; King J; Kotzuk J; Schoepp DD; Frost J; Schochet S
    J Neurochem; 1985 Sep; 45(3):949-56. PubMed ID: 3928811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A and B forms of monoamine oxidase within the monoaminergic neurons of the rat brain.
    Fagervall I; Ross SB
    J Neurochem; 1986 Aug; 47(2):569-76. PubMed ID: 3734795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra- and extra-dopamine-synaptosomal localization of monoamine oxidase in striatal homogenates from four species.
    Stenström A; Hardy J; Oreland L
    Biochem Pharmacol; 1987 Sep; 36(18):2931-5. PubMed ID: 3632718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain dialysis: in vivo metabolism of dopamine and serotonin by monoamine oxidase A but not B in the striatum of unrestrained rats.
    Kato T; Dong B; Ishii K; Kinemuchi H
    J Neurochem; 1986 Apr; 46(4):1277-82. PubMed ID: 2419508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of rat striatal monoamine oxidase activities towards dopamine, serotonin and kynuramine by gradient centrifugation and nigro-striatal lesions.
    Van der Krogt JA; Koot-Gronsveld E; Van den Berg CJ
    Life Sci; 1983 Aug; 33(7):615-23. PubMed ID: 6877035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uptake and metabolism of catecholamines in rat brain synaptosomes: studies on the contribution of monoamine oxidase.
    Urwyler S; von Wartburg JP
    Biochem Pharmacol; 1981 Oct; 30(20):2777-85. PubMed ID: 7332636
    [No Abstract]   [Full Text] [Related]  

  • 8. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correspondence of its binding sites to monoamine oxidase in rat brain, and inhibition of dopamine oxidative deamination in vivo and in vitro.
    Bocchetta A; Piccardi MP; Del Zompo M; Pintus S; Corsini GU
    J Neurochem; 1985 Sep; 45(3):673-6. PubMed ID: 3928808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between cytosolic monoamine oxidase and spin-labeled amphetamine and its modification by clorgyline and pargyline.
    Copeland ES; Campbell IC; Murphy DL
    Biochim Biophys Acta; 1983 Feb; 743(1):186-94. PubMed ID: 6824699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of different monoamine oxidase inhibitors on the metabolism of L-dopa in the rat brain.
    Nguyen TB; Angers M
    Biochem Pharmacol; 1987 May; 36(10):1731-5. PubMed ID: 3109430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early effects of monoamine oxidase inhibitors on dopamine metabolism and monoamine oxidase activity in the neostriatum of the rat.
    Javoy F; Youdim MB; Agid Y; Glowinski J
    J Neural Transm; 1973; 34(4):279-89. PubMed ID: 4149516
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on the subcellular localization of monoamine oxidase types A and B and its importance for the deamination of dopamine in the rat brain.
    Urwyler S; von Wartburg JP
    Biochem Pharmacol; 1980 Nov; 29(22):3067-73. PubMed ID: 6779822
    [No Abstract]   [Full Text] [Related]  

  • 13. Type A monoamine oxidase catalyzes the intraneuronal deamination of dopamine within nigrostriatal, mesolimbic, tuberoinfundibular and tuberohypophyseal neurons in the rat.
    Demarest KT; Moore KE
    J Neural Transm; 1981; 52(3):175-87. PubMed ID: 6796650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of type A and type B monoamine oxidase in the metabolism of released [3H]dopamine from rat striatal slices.
    Schoepp DD; Azzaro AJ
    Biochem Pharmacol; 1982 Sep; 31(18):2961-8. PubMed ID: 6814449
    [No Abstract]   [Full Text] [Related]  

  • 15. Selective monoamine oxidase subtype inhibition and striatal extracellular dopamine in the guinea-pig.
    Ilani T; Lamensdorf I; Finberg JP
    Br J Pharmacol; 2000 Aug; 130(8):1992-8. PubMed ID: 10952692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specificity of endogenous substrates for types A and B monoamine oxidase in rat striatum.
    Schoepp DD; Azzaro AJ
    J Neurochem; 1981 Jun; 36(6):2025-31. PubMed ID: 6787175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carrier-mediated efflux of [3H]dopamine and [3H]1-methyl-4-phenylpyridine: effect of ascorbic acid.
    Debler EA; Sershen H; Hashim A; Lajtha A; Reith ME
    Synapse; 1991 Feb; 7(2):99-105. PubMed ID: 2011830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of monoamine oxidase-B by (-)-deprenyl potentiates neuronal responses to dopamine agonists but does not inhibit dopamine catabolism in the rat striatum.
    Paterson IA; Juorio AV; Berry MD; Zhu MY
    J Pharmacol Exp Ther; 1991 Sep; 258(3):1019-26. PubMed ID: 1679846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of repeated doses of (-) deprenyl on the dynamics of monoaminergic transmission. Comparison with clorgyline.
    Zsilla G; Földi P; Held G; Székely AM; Knoll J
    Pol J Pharmacol Pharm; 1986; 38(1):57-67. PubMed ID: 3020531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.
    Fisar Z; Hroudová J; Raboch J
    Neuro Endocrinol Lett; 2010; 31(5):645-56. PubMed ID: 21200377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.